ATA240692A - Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat - Google Patents

Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat

Info

Publication number
ATA240692A
ATA240692A AT0240692A AT240692A ATA240692A AT A240692 A ATA240692 A AT A240692A AT 0240692 A AT0240692 A AT 0240692A AT 240692 A AT240692 A AT 240692A AT A240692 A ATA240692 A AT A240692A
Authority
AT
Austria
Prior art keywords
ranitide
inismutcitrate
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
AT0240692A
Other languages
English (en)
Other versions
AT401468B (de
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919126027A external-priority patent/GB9126027D0/en
Priority claimed from GB929206083A external-priority patent/GB9206083D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ATA240692A publication Critical patent/ATA240692A/de
Application granted granted Critical
Publication of AT401468B publication Critical patent/AT401468B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT0240692A 1991-12-06 1992-12-04 Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat AT401468B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919126027A GB9126027D0 (en) 1991-12-06 1991-12-06 Medicaments
GB929206083A GB9206083D0 (en) 1992-03-20 1992-03-20 Medicaments

Publications (2)

Publication Number Publication Date
ATA240692A true ATA240692A (de) 1996-02-15
AT401468B AT401468B (de) 1996-09-25

Family

ID=26299971

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0240692A AT401468B (de) 1991-12-06 1992-12-04 Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat

Country Status (26)

Country Link
US (1) US5466436A (de)
EP (1) EP0550083B1 (de)
JP (1) JPH05246853A (de)
KR (1) KR930009605A (de)
AP (1) AP324A (de)
AT (1) AT401468B (de)
AU (1) AU664574B2 (de)
BE (1) BE1007268A3 (de)
CA (1) CA2084568A1 (de)
CH (1) CH685537A5 (de)
CZ (1) CZ358092A3 (de)
DE (1) DE69228738D1 (de)
DK (1) DK0550083T3 (de)
ES (1) ES2130152T3 (de)
FR (1) FR2684554B1 (de)
GB (1) GB2262036B (de)
GR (1) GR3030426T3 (de)
IE (1) IE922866A1 (de)
IL (1) IL103978A (de)
IT (1) IT1256697B (de)
LU (1) LU88196A1 (de)
MX (1) MX9207008A (de)
MY (1) MY108146A (de)
NO (1) NO303670B1 (de)
NZ (1) NZ245365A (de)
PH (1) PH31380A (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
JPH10512877A (ja) * 1995-01-26 1998-12-08 ニコムド イメージング エイ／エス ビスマス化合物
EP0941101A1 (de) * 1996-11-22 1999-09-15 The Procter & Gamble Company Zusammensetzungen zur behandlung von gastrointestinalen störungen, welche wismuth, einen nsaid und eine oder mehrere antimikrobielle mitteln enthalten
TR199901101T2 (xx) * 1996-11-22 1999-07-21 The Procter & Gamble Company Gastroenstentinal hastal�klar�n tedavisine y�nelik bizmut ve nsaid i�eren bile�imler.
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
MXPA03007888A (es) * 2001-03-08 2003-12-04 Astrazeneca Ab Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos.
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
AU2002305758B2 (en) * 2001-06-01 2006-09-07 Nuvo Pharmaceuticals (Ireland) Designated Activity Company Pharmaceutical compositions for the coordinated delivery of NSAIDs
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US20080021078A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Methods and medicaments for administration of ibuprofen
US8067451B2 (en) * 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
EP1919288A4 (de) * 2005-07-18 2009-12-16 Horizon Therapeutics Inc Famotidin- und ibuprofenhaltige arzneimittel und ihre verabreichung
US20080020040A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Unit dose form for administration of ibuprofen
US8067033B2 (en) 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
US20100297224A1 (en) * 2006-08-31 2010-11-25 Horizon Therapeutics, Inc. NSAID Dose Unit Formulations with H2-Receptor Antagonists and Methods of Use
US9220698B2 (en) 2008-09-09 2015-12-29 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
KR20120030106A (ko) 2009-06-25 2012-03-27 아스트라제네카 아베 Ｎｓａｉｄ-연관된 궤양의 발생 위험이 있는 환자의 치료 방법
EP2797600A4 (de) 2011-12-28 2015-09-16 Pozen Inc Verbesserte zusammensetzungen und verfahren zur abgabe von omeprazol und acetylsalicylsäure
CN110893233A (zh) * 2019-12-19 2020-03-20 川北医学院附属医院 一种鸢尾素在制备抗炎药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464679A (en) * 1981-07-06 1984-08-07 Rca Corporation Method and apparatus for operating a microprocessor in synchronism with a video signal
GB2105193B (en) * 1981-09-04 1984-09-12 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
CA1211374A (en) * 1982-05-14 1986-09-16 Eszter Cholnoky Pharmaceutical compositions containing more active ingredients
US4757060A (en) * 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
CH679582A5 (de) * 1988-07-18 1992-03-13 Glaxo Group Ltd
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions

Also Published As

Publication number Publication date
US5466436A (en) 1995-11-14
PH31380A (en) 1998-10-29
IL103978A0 (en) 1993-05-13
IT1256697B (it) 1995-12-12
IL103978A (en) 1998-06-15
ITRM920869A0 (it) 1992-12-04
AU664574B2 (en) 1995-11-23
EP0550083B1 (de) 1999-03-24
MX9207008A (es) 1993-06-01
GB2262036A (en) 1993-06-09
GB2262036B (en) 1996-01-03
LU88196A1 (fr) 1993-08-17
MY108146A (en) 1996-08-30
CA2084568A1 (en) 1993-06-07
DK0550083T3 (da) 1999-10-11
FR2684554A1 (fr) 1993-06-11
AP324A (en) 1994-03-07
NZ245365A (en) 1997-06-24
BE1007268A3 (fr) 1995-05-09
FR2684554B1 (fr) 1995-09-08
AP9200453A0 (en) 1993-01-31
DE69228738D1 (de) 1999-04-29
CZ358092A3 (en) 1993-10-13
GR3030426T3 (en) 1999-09-30
GB9225174D0 (en) 1993-01-20
ITRM920869A1 (it) 1994-06-04
ES2130152T3 (es) 1999-07-01
KR930009605A (ko) 1993-06-21
IE922866A1 (en) 1993-06-16
AU2986392A (en) 1993-06-10
CH685537A5 (fr) 1995-08-15
EP0550083A1 (de) 1993-07-07
NO924704D0 (no) 1992-12-04
NO924704L (no) 1993-06-07
JPH05246853A (ja) 1993-09-24
NO303670B1 (no) 1998-08-17
AT401468B (de) 1996-09-25

Similar Documents

Publication Publication Date Title
ATA129892A (de) Pharmazeutische zusammensetzung
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
FI922252L (fi) Farmaceutisk sammansaettning
FI922316L (fi) Farmaceutisk sammansaettning
ATE203400T1 (de) Pharmazeutische formulierungen
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
DE10199066I1 (de) Pharmazeutische Zusammensetzung
ATA240692A (de) Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat
FI923582A7 (fi) Farmaseuttinen sferoidikoostumus
NO923127L (no) Farmasoeytisk kombinasjonsformulering
BR9200058A (pt) Composto e composicao farmaceutica
ITRM910952A0 (it) Composizioni farmaceutiche contenenti gonadotropine
FI893643A7 (fi) Farmaseuttisia koostumuksia
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
MX9200622A (es) Composicion farmaceutica
DE4294862T1 (de) Pharmazeutische Komposition
GB2251617B (en) Pharmaceutical compositions containing substituted 3-hydroxypyridin-4-ones
FI952377A7 (fi) Farmaseuttisia ibuprofeenikoostumuksia
DE69122229D1 (de) Penciclovir enthaltende pharmazeutische formulierung
FI921786A7 (fi) Farmaceutisk foerening
FI921785A7 (fi) Farmaceutisk foerening
FI923869L (fi) Farmaceutiska aemnen
DE68902056D1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
FI910773A7 (fi) Episialo-hiilihydraattikompleksia sisältävä farmaseuttinen koostumus
ITMI912766A1 (it) Composizione farmaceutica contenente n-acetil-cisteina

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee